Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration

2019-12-03T08:32:31+00:00

Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration to accelerate neuroscience-focused research Initial twelve month collaboration successfully identifies hit compounds and progresses into hit-to-lead optimisation phase Cambridge and London, UK, 03 December 2019: Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, a leading UK independent medical [...]